Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Imidazole bearing chalcones as a new class of monoamine oxidase inhibitors
Rani Sasidharan, Seung Cheol Baek, Manju Sreedharannair Leelabaiamma, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 106, pp. 8-13
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Synthesis of Chalcones Derivatives and Their Biological Activities: A Review
Nadia A. A. Elkanzi, Hajer Hrichi, Ruba A. Alolayan, et al.
ACS Omega (2022) Vol. 7, Iss. 32, pp. 27769-27786
Open Access | Times Cited: 194
Chalcone: A Promising Bioactive Scaffold in Medicinal Chemistry
Gayathri Rajendran, Deepu Bhanu, Baladhandapani Aruchamy, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 10, pp. 1250-1250
Open Access | Times Cited: 68
Synthesis and Pharmacological Activities of Chalcone and Its Derivatives Bearing N-Heterocyclic Scaffolds: A Review
Kibrom Mezgebe, Yadessa Melaku, Endale Mulugeta
ACS Omega (2023) Vol. 8, Iss. 22, pp. 19194-19211
Open Access | Times Cited: 48
Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases
Bijo Mathew, Della Grace Thomas Parambi, Githa Elizabeth Mathew, et al.
Archiv der Pharmazie (2019) Vol. 352, Iss. 11
Closed Access | Times Cited: 119
Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors
Paolo Guglielmi, Bijo Mathew, Daniela Secci, et al.
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112650-112650
Closed Access | Times Cited: 69
Design, synthesis and biological evaluation of oxygenated chalcones as potent and selective MAO-B inhibitors
Della Grace Thomas Parambi, Jong‐Min Oh, Seung Cheol Baek, et al.
Bioorganic Chemistry (2019) Vol. 93, pp. 103335-103335
Closed Access | Times Cited: 60
Introduction of benzyloxy pharmacophore into aryl/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors
Sachithra Thazhathuveedu Sudevan, Jong‐Min Oh, Mohamed A. Abdelgawad, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Recent pharmacological insights about imidazole hybrids: a comprehensive review
Samet Poyraz, Metin Yıldırım, Mehmet Erşatır
Medicinal Chemistry Research (2024) Vol. 33, Iss. 6, pp. 839-868
Closed Access | Times Cited: 6
Probing the inhibition of MAO-B by chalcones: an integrated approach combining molecular docking, ADME analysis, MD simulation, and MM-PBSA calculations
Jisna Jose, Jibin K. Varughese, Mohammad K. Parvez, et al.
Journal of Molecular Modeling (2024) Vol. 30, Iss. 4
Closed Access | Times Cited: 5
The pivotal role of the carbonyl group in methoxy chalcones: comprehensive analyses of the structure and computational insights into binding affinity towards monoamine oxidase enzymes
Keshav Kumar Harish, Hussien Ahmed Khamees, Keerthikumara Venkatesha, et al.
Molecular Systems Design & Engineering (2025)
Closed Access
Potent and highly selective dual‐targeting monoamine oxidase‐B inhibitors: Fluorinated chalcones of morpholine versus imidazole
Bijo Mathew, Seung Cheol Baek, Della Grace Thomas Parambi, et al.
Archiv der Pharmazie (2019) Vol. 352, Iss. 4
Closed Access | Times Cited: 52
Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer’s disease: Design, synthesis and biological evaluation
Chaoquan Tian, Xiaoming Qiang, Qing Song, et al.
Bioorganic Chemistry (2019) Vol. 94, pp. 103477-103477
Closed Access | Times Cited: 52
Perspective Design of Chalcones for the Management of CNS Disorders: A Mini-Review
Bijo Mathew, Della Grace Thomas Parambi, Vishnu Sankar Sivasankarapillai, et al.
CNS & Neurological Disorders - Drug Targets (2019) Vol. 18, Iss. 6, pp. 432-445
Closed Access | Times Cited: 46
Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors
Jong‐Min Oh, T. M. Rangarajan, Reeta Chaudhary, et al.
Molecules (2020) Vol. 25, Iss. 10, pp. 2356-2356
Open Access | Times Cited: 46
Piperazine-substituted chalcones: a new class of MAO-B, AChE, and BACE-1 inhibitors for the treatment of neurological disorders
Bijo Mathew, Jong‐Min Oh, Roua S. Baty, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 29, pp. 38855-38866
Open Access | Times Cited: 38
Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations
Rani Sasidharan, Bo Hyun Eom, Jeong Hyun Heo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 188-197
Open Access | Times Cited: 33
An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects
Pratibha Sharma, Manjinder Singh
Life Sciences (2023) Vol. 320, pp. 121568-121568
Closed Access | Times Cited: 14
Selected aryl thiosemicarbazones as a new class of multi-targeted monoamine oxidase inhibitors
Bijo Mathew, Seung Cheol Baek, Della Grace Thomas Parambi, et al.
MedChemComm (2018) Vol. 9, Iss. 11, pp. 1871-1881
Open Access | Times Cited: 45
Trimethoxylated Halogenated Chalcones as Dual Inhibitors of MAO-B and BACE-1 for the Treatment of Neurodegenerative Disorders
Vishal Payyalot Vishal, Jong‐Min Oh, Ahmed Khames, et al.
Pharmaceutics (2021) Vol. 13, Iss. 6, pp. 850-850
Open Access | Times Cited: 29
Ethyl Acetohydroxamate Incorporated Chalcones: Unveiling a Novel Class of Chalcones for Multitarget Monoamine Oxidase-B Inhibitors Against Alzheimer’s Disease
Reeta Reeta, Seung Cheol Baek, Jae Pil Lee, et al.
CNS & Neurological Disorders - Drug Targets (2019) Vol. 18, Iss. 8, pp. 643-654
Closed Access | Times Cited: 31
Ethoxylated Head of Chalcones as a New Class of Multi‐Targeted MAO Inhibitors
Balasubramanian Lakshminarayanan, Seung Cheol Baek, Jae Pil Lee, et al.
ChemistrySelect (2019) Vol. 4, Iss. 21, pp. 6614-6619
Closed Access | Times Cited: 29
Unraveling the Structural Requirements of Chalcone Chemistry Towards Monoamine Oxidase Inhibition
Bijo Mathew
Central Nervous System Agents in Medicinal Chemistry (2019) Vol. 19, Iss. 1, pp. 6-7
Closed Access | Times Cited: 25
Potent and selective inhibition of human monoamine oxidase-B by 4-dimethylaminochalcone and selected chalcone derivatives
Jong‐Min Oh, Myung-Gyun Kang, Ahreum Hong, et al.
International Journal of Biological Macromolecules (2019) Vol. 137, pp. 426-432
Closed Access | Times Cited: 25
Chalcones bearing N, O, and S-heterocycles: Recent notes on their biological significances
Bayu Ardiansah
Journal of Applied Pharmaceutical Science (2019) Vol. 9, Iss. 8, pp. 117-129
Open Access | Times Cited: 24
Design, Synthesis and Docking Calculations of Prenylated Chalcones as Selective Monoamine Oxidase B Inhibitors with Antioxidant Activity
Marco Mellado, Cristian O. Salas, Eugenio Uriarte, et al.
ChemistrySelect (2019) Vol. 4, Iss. 26, pp. 7698-7703
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top